ADAM VOGEL to Morpholines
This is a "connection" page, showing publications ADAM VOGEL has written about Morpholines.
Connection Strength
0.215
-
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202. ESMO Open. 2024 Jun; 9(6):103488.
Score: 0.215
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.